| answer text |
<p>The National Institute for Health and Care Excellence (NICE) is an independent
body and is responsible for the methods and processes used in the development of its
technology appraisal and highly specialised technologies recommendations. NICE has
now initiated the review of its technology appraisal and highly specialised technologies
methods in line with the commitment made in the 2019 Voluntary Scheme for Branded
Medicines Pricing and Access.</p><p> </p><p>The Voluntary Scheme states that industry
and other relevant stakeholders will be active participants in the review, including
inputting on scope, participating in working discussions, and providing views on recommendations.
NICE’s updated methods guide will also be subject to a public consultation.</p><p>
</p><p>NICE has established a working group, consisting of members from NICE, NHS
England, the Department, patient organisations and the life sciences industry. The
working group reports to a steering group, chaired by NICE and with members from NHS
England, the Department, and an independent academic methodologist. The steering group
will present its recommendations to NICE’s Senior Management Team, which in turn will
report to the NICE Board. NICE approached patient groups with experience of NICE and
its processes and methods. There are three patient group representatives on the working
group with a wide range of experience, covering a range of topic areas, reflecting
the programmes under review. Membership of the working group will be published in
due course.</p><p> </p><p>NICE is now in the process of scoping the review of the
methods for technology appraisal and highly specialised technologies evaluations with
input from the working group and steering group. The scope of the review - a list
of the aspects of NICE’s current methods that will be considered in the review - will
be presented to the NICE Board in July. Additional detail and more information will
be made available on the NICE website in due course. NICE anticipates being in a position
to confirm the revised methods guide by the end of 2020, following public consultation.</p><p>
</p><p><strong> </strong></p><p><strong> </strong></p>
|
|
